Cite
HARVARD Citation
Khanna, D. et al. (n.d.). THU0328 SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN SYSTEMIC SCLEROSIS: RESULTS FROM THE OPEN-LABEL PERIOD OF THE PHASE 3 FOCUSSCED TRIAL. Annals of the rheumatic diseases. p. 394. [Online].